Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma
- 3 June 2003
- journal article
- case report
- Published by Wiley in Arthritis Care & Research
- Vol. 49 (3), 394-398
- https://doi.org/10.1002/art.11109
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Sjögren’s syndrome: current therapies remain inadequate for a common diseaseExpert Opinion on Investigational Drugs, 2000
- The use of oral pilocarpine in xerostomiaand sjögren's syndromeSeminars in Arthritis and Rheumatism, 1999
- Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome.JCI Insight, 1998
- Immunohistological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glands.Journal of Clinical Pathology, 1996
- The etiopathogenesis of Sjögren's syndromeSeminars in Arthritis and Rheumatism, 1995
- Epidemiology, pathogenesis, animal models, and treatment of Sjögrenʼs syndromeCurrent Opinion in Rheumatology, 1994
- Morphometric Analysis of Airways in Sjögren's SyndromeAmerican Review of Respiratory Disease, 1993
- Autoantibody synthesis in salivary glands of Sjögren's syndrome patientsJournal of Autoimmunity, 1989
- Sjögren's Syndrome (Sicca Syndrome): Current IssuesAnnals of Internal Medicine, 1980
- Increased Risk of Lymphoma in Sicca SyndromeAnnals of Internal Medicine, 1978